OCTAVE study reveals vaccine response in patients with impaired immune systems
Preliminary data from the OCTAVE study in August 2021 showed that a significant proportion of clinically at-risk patients with…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
University of Oxford
UK health service rolls out arthritis drug Baricitinib to treat COVID
Arthritis drugs work by reducing inflammation caused by COVID-19 by blocking signals to the immune system that are causing it to…
Arthritis drug shown to reduce risk of COVID death in large UK trial
More than 8,000 patients were administered baricitinib in addition to usual care, at random, or usual care alone, as part of the…
University of Oxford study supports use of Vaxzevria as third-dose booster against Omicron
Neutralising anti-body levels against Omicron following a third-dose boost of Vaxzevria were broadly similar to levels achieved…
Oxford study indicates AstraZeneca’s COVID-19 vaccine woks against Brazil variant: Report
The exact efficacy of the vaccine against the variant is not known
University of Oxford to assess COVID-19 vaccine response among children for first time
The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17
INEOS, Oxford University to set up institute for antimicrobial research
INEOS donates £100 million to Oxford Univerity to set up the new institute to fight antimicrobial resistance
Awaiting India’s approval for COVISHIELD: SII
The company made this statement after UK's approval of the Oxford-AstraZeneca COVID-19 vaccine
AstraZeneca-Oxford University COVID-19 vaccine may get rolled out in six months or less
If it is approved by the regulators, the UK’s NHS is said to be in a position to begin mass vaccination almost immediately
AstraZeneca stops COVID-19 vaccine trial due to unexplained illness in participant
A participant was found to have transverse myelitis, an inflammatory syndrome that affects the spinal cord and is often sparked by…